药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Paricalcitol
Diazoxide
The therapeutic efficacy of Diazoxide can be decreased when used in combination with Aminophenazone.
Paricalcitol
Trimethaphan
The therapeutic efficacy of Trimethaphan can be decreased when used in combination with Aminophenazone.
Paricalcitol
Pentolinium
The therapeutic efficacy of Pentolinium can be decreased when used in combination with Aminophenazone.
Paricalcitol
Deserpidine
The therapeutic efficacy of Deserpidine can be decreased when used in combination with Aminophenazone.
Paricalcitol
Betrixaban
The risk or severity of bleeding can be increased when Betrixaban is combined with Aminophenazone.
Paricalcitol
Vemurafenib
The serum concentration of Aminophenazone can be increased when it is combined with Vemurafenib.
Paricalcitol
Sodium phosphate, monobasic
The risk or severity of renal failure can be increased when Sodium phosphate, monobasic is combined with Aminophenazone.
Paricalcitol
Osimertinib
The serum concentration of Aminophenazone can be decreased when it is combined with Osimertinib.
Paricalcitol
Certoparin
The risk or severity of hyperkalemia can be increased when Aminophenazone is combined with Certoparin.
Paricalcitol
Tolvaptan
The risk or severity of hyperkalemia can be increased when Aminophenazone is combined with Tolvaptan.
Paricalcitol
Tetrandrine
The risk or severity of hyperkalemia can be increased when Aminophenazone is combined with Tetrandrine.
Paricalcitol
Lomerizine
The risk or severity of hyperkalemia can be increased when Aminophenazone is combined with Lomerizine.
Paricalcitol
Emopamil
The risk or severity of hyperkalemia can be increased when Aminophenazone is combined with Emopamil.
Paricalcitol
Dexverapamil
The risk or severity of hyperkalemia can be increased when Aminophenazone is combined with Dexverapamil.
Paricalcitol
Fish oil
The risk or severity of hyperkalemia can be increased when Aminophenazone is combined with Fish oil.
Paricalcitol
WIN 55212-2
The risk or severity of hyperkalemia can be increased when Aminophenazone is combined with WIN 55212-2.
Paricalcitol
Caroverine
The risk or severity of hyperkalemia can be increased when Aminophenazone is combined with Caroverine.
Paricalcitol
Penfluridol
The risk or severity of hyperkalemia can be increased when Aminophenazone is combined with Penfluridol.
Paricalcitol
Lidoflazine
The risk or severity of hyperkalemia can be increased when Aminophenazone is combined with Lidoflazine.
Paricalcitol
Terodiline
The risk or severity of hyperkalemia can be increased when Aminophenazone is combined with Terodiline.